← Eichor
Study identifier: NCT06060548 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Role of Novel ILR in the Management of PVCs

Condition: PVC - Premature Ventricular Contraction · Myocarditis  ·  Sponsor: Kansas City Heart Rhythm Research Foundation

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.

This description comes directly from the study's public registry record.

Talk to the study team

Donita Atkins  ·  816-651-1969  ·  datkins@kchrf.com

Always discuss trial participation with your own doctor first.

Locations (6)

Kansas City Heart Rhythm Institute - Roe ClinicOverland Park, Kansas, United StatesRecruiting
Overland Park Regional Medical CenterOverland Park, Kansas, United StatesRecruiting
Centerpoint Medical Center ClinicIndependence, Missouri, United StatesRecruiting
Centerpoint Medical CenterIndependence, Missouri, United StatesRecruiting
Research Medical Center ClinicKansas City, Missouri, United StatesRecruiting
Research Medical CenterKansas City, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06060548